RECENT PLACEMENT

Occam Recruits Sales and Operations Leader to the Board of Geron

Occam Recruits Sales and Operations Leader to the Board of Geron

In March 2019, Occam Global recruited Dawn C. Bir to the Board of Geron Corporation, a public commercial-stage oncology biotech. Bir also serves on the Board of Soleno Therapeutics and was the Chief Commercial Officer at Reata Pharmaceuticals from September 2016 until Biogen’s $7.3B acquisition of Reata in 2023. Prior to her time at Reata, she held several key leadership positions at Pharmacyclics, McKesson, Genentech, and Bristol-Myers Squibb, demonstrating a strong track record in sales, operations, and team development across various therapeutic areas.

‍

Read more about Occam's work with Geron in our case study.

‍

Recent Placements

  1. Carolyn Haley as COO at F-Prime Capital
  2. Chau Cheng as VP of Investor Relations & Corporate Communications at Cytomx
  3. Bryan Stuart as CEO of Atavistik
  4. Bimal Shah as CFO of Corium
  5. Bell Zhong as CFO at Neomorph
  6. Occam Recruits Sapna Srivastava to the Board of Nuvalent
  7. Occam's Tech Practice Places CRO at Engageli
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.